Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
NCT04130464
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA combined with an NSAID compared with a control group who receives only 0.9% normal saline.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hysterectomy
- Gynecologic Surgical Procedures
- Narcotic Use
- Pain, Postoperative
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 to 65 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Ying Liu
- Last updated on ClinicalTrials.gov
- April 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
District of Columbia · 2
- MedStar Washington Hospital Center · Washington D.C., DC
- The GW Medical Faculty Associates · Washington D.C., DC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.